Gunderson, L. L. and Sosin, H.Areas of failure found at reoperation (second or symptomatic look) following “curative surgery” for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy. Cancer 34 (1974), 1278–92.3.0.CO;2-F>CrossRefGoogle ScholarPubMed

Wiig, J. N., Wolff, P. A., Tveit, K. M., et al. Location of pelvic recurrence after ‘curative’ low anterior resection for rectal cancer. Eur J Surg Oncol, 25 (1999), 590–4.CrossRefGoogle ScholarPubMed

Hruby, G., Barton, M., Miles, S., et al. Sites of local recurrence after surgery, with or without chemotherapy, for rectal cancer: implications for radiotherapy field design. Int J Radiat Oncol Biol Phys, 55 (2003), 138–43.CrossRefGoogle ScholarPubMed

Steup, W. H., Moriya, Y., and Velde, C. J.Patterns of lymphatic spread in rectal cancer. A topographical analysis on lymph node metastases. Eur J Cancer, 38 (2002), 911–18.CrossRefGoogle ScholarPubMed

Hocht, S., Hammad, R., Thiel, H. J., et al. Recurrent rectal cancer within the pelvis. A multicenter analysis of 123 patients and recommendations for adjuvant radiotherapy. Strahlenther Onkol, 180 (2004), 15–20.CrossRefGoogle ScholarPubMed

Fisher, B., Wolmark, N., Rockette, H., et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst, 80 (1988), 21–9.CrossRefGoogle ScholarPubMed

Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Medical Research Council Rectal Cancer Working Party. Lancet, 348 (1996), 1610–14.CrossRef

Prolongation of the disease-free interval in surgically treated rectal carcinoma. Gastrointestinal Tumor Study Group. N Engl J Med 312 (1985), 1465–72.CrossRef

Wolmark, N., Wieand, H. S., Hyams, D. M., et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst, 92 (2000), 388–96.CrossRefGoogle ScholarPubMed

Roh, M., Petrelli, N., Wieand, S., et al. Phase III randomized trial of preoperative versus postoperative mutimodality therapy in patients with carcinoma of the rectum (NSABPR-03). 2001 ASCO General Meeting (2005), abstr 490.

Sauer, R., Becker, H., Hohenberger, W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med, 351 (2004), 1731–40.CrossRefGoogle ScholarPubMed

Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med, 336 (1997), 980–7.CrossRef

Kapiteijn, E., Marijnen, C. A., Nagtegaal, I. D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med, 345 (2001), 638–46.CrossRefGoogle ScholarPubMed

Marijnen, C. A., Nagtegaal, I. D., Kapiteijn, E., et al. Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys, 55 (2003), 1311–20.CrossRefGoogle Scholar

Bosset, J. F., Calais, G., Mineur, L., et al. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results – EORTC 22921. J Clin Oncol, 23 (2005), 5620–7.CrossRefGoogle ScholarPubMed

Sebag-Montefiore, D., Steele, R., Quirke, P., et al. Routine short course pre-op radiotherapy or selective post-op chemoradiotherapy for resectable rectal cancer? Preliminary results of the MRC CR07 randomised trial. J Clin Oncol (Meeting Abstracts), 24 (2006), 3511 [Abstract].Google Scholar

Nagtegaal, I. D., Velde, C. J., Worp, E., et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol, 20 (2002), 1729–34.CrossRefGoogle ScholarPubMed

Bujko, K., Nowacki, M. P., Nasierowska-Guttmejer, A., et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg, 93 (2006), 1215–23.CrossRefGoogle ScholarPubMed

Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. Bmj, 333 (2006), 779.CrossRef

Marr, R., Birbeck, K., Garvican, J., et al. The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg, 242 (2005), 74–82.CrossRefGoogle ScholarPubMed

AJCC Cancer Staging Handbook Sixth edition (American Joint Committe on Cancer, 2002).

Bujko, K., Nowacki, M. P., Nasierowska-Guttmejer, A., et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 72 (2004), 15–24.CrossRefGoogle ScholarPubMed

Mawdsley, S. and Glynne-Jones, R. The importance of pathological downstaging and the circumferential margin in rectal carcinomas treated with neoadjuvant chemoradiation. ASCO Annual Meeting, (2005), abstr 3642.

Balch, G. C., Mithani, S. K., Shyr, Y., et al. Prognostic significance of response to neoadjuvant chemoradiation therapy for rectal cancer. ASCO Annual Meeting (2003), abstr 1047.

Shivnani, T., Small, W., Stryker, S. J., et al. Preoperative chemoradiation in Rectal Cancer: correlation of tumor response with survival. J Clin Oncol Proc (2004), abstr 247.Google Scholar

Rodel, C., Martus, P., Papadoupolos, T., et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol, 23 (2005), 8688–96.CrossRefGoogle ScholarPubMed

Vecchio, F. M., Valentini, V., Minsky, B. D., et al. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys, 62 (2005), 752–60.CrossRefGoogle ScholarPubMed

Pucciarelli, S., Toppan, P., Friso, M. L., et al. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Dis Colon Rectum, 47 (2004), 1798–807.CrossRefGoogle Scholar

Glynne-Jones, R. and Anyamene, N. Just how useful an endpoint is complete pathological response after neoadjuvant chemoradiation in rectal cancer?Int J Radiat Oncol Biol Phys, 66 (2006), 319–20.CrossRefGoogle ScholarPubMed

Francois, Y., Nemoz, C. J., Baulieux, J., et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90–01 randomized trial. J Clin Oncol, 17 (1999), 2396.CrossRefGoogle ScholarPubMed

Goldberg, P. A., Nicholls, R. J., Porter, N. H., et al. Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: reduction in local treatment failure. Eur J Cancer, 30A (1994), 1602–6.CrossRefGoogle ScholarPubMed

Gerard, J. P., Chapet, O., Nemoz, C., et al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon R96–02 randomized trial. J Clin Oncol, 22 (2004), 2404–9.CrossRefGoogle ScholarPubMed

Jakobsen, A., Mortensen, J. P., Bisgaard, C., et al. Preoperative chemoradiation of locally advanced T3 rectal cancer combined with an endorectal boost. Int J Radiat Oncol Biol Phys, 64 (2006), 461–5.CrossRefGoogle ScholarPubMed

J clin Oncol, 23 (2005), 8688–96.

Oncol, Lancet, 8 (2007), 625–33.

Andreyev, J.Gastrointestinal complications of pelvic radiotherapy: are they of any importance?Gut, 54 (2005), 1051–4.CrossRefGoogle ScholarPubMed

Peeters, K. C., Velde, C. J., Leer, J. W., et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients – a Dutch colorectal cancer group study. J Clin Oncol, 23 (2005), 199–206.CrossRefGoogle ScholarPubMed

Dahlberg, M., Glimelius, B., Graf, W., et al. Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study. Dis Colon Rectum, 41 (1998), 543–9, discussion 549–51.CrossRefGoogle ScholarPubMed

Hermann, R. M., Henkel, K., Christiansen, H., et al. Testicular dose and hormonal changes after radiotherapy of rectal cancer. Radiother Oncol 75 (2005), 83–8.CrossRefGoogle ScholarPubMed

Mazonakis, M., Damilakis, J., Varveris, H., et al. Radiation dose to testes and risk of infertility from radiotherapy for rectal cancer. Oncol Rep 15 (2006), 729–33.Google ScholarPubMed

Fraass, B. A., Kinsella, T. J., Harrington, F. S., et al. Peripheral dose to the testes: the design and clinical use of a practical and effective gonadal shield. Int J Radiat Oncol Biol Phys, 11 (1985), 609–15.CrossRefGoogle ScholarPubMed

Kubo, H. and Shipley, W. U.Reduction of the scatter dose to the testicle outside the radiation treatment fields. Int J Radiat Oncol Biol Phys, 8 (1982), 1741–5.CrossRefGoogle ScholarPubMed

Budgell, G. J., Cowan, R. A., and Hounsell, A. R.Prediction of scattered dose to the testes in abdominopelvic radiotherapy. Clin Oncol (R Coll Radiol), 13 (2001), 120–5.Google ScholarPubMed

Piroth, M. D., Hensley, F., Wannenmacher, M., et al. [Male gonadal dose in adjuvant 3-d-pelvic irradiation after anterior resection of rectal cancer. Influence to fertility]. Strahlenther Onkol, 179 (2003), 754–9.CrossRefGoogle ScholarPubMed

Spinelli, S., Chiodi, S., Bacigalupo, A., et al. Ovarian recovery after total body irradiation and allogeneic bone marrow transplantation: long-term follow up of 79 females. Bone Marrow Transplant, 14 (1994), 373–80.Google ScholarPubMed

Bisharah, M. and Tulandi, T.Laparoscopic preservation of ovarian function: an underused procedure. Am J Obstet Gynecol, 188 (2003), 367–70.CrossRefGoogle Scholar

Marijnen, C. A., Velde, C. J., Putter, H., et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol, 23 (2005), 1847–58.CrossRefGoogle ScholarPubMed

Birgisson, H., Pahlman, L., Gunnarsson, U., et al. Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol, 23 (2005), 6126–31.CrossRefGoogle ScholarPubMed

Frykholm, G. J., Glimelius, B., and Pahlman, L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum, 36 (1993), 564–72.CrossRefGoogle ScholarPubMed

Bentrem, D. J., Okabe, S., Wong, W. D., et al. T1 adenocarcinoma of the rectum: transanal excision or radical surgery?Ann Surg, 242 (2005), 472–7, discussion 477–9.Google ScholarPubMed

You, Y. N., Baxter, N., Stewart, A., et al. Is local excision adequate for T1 rectal cancer? A nationwide cohort study from the national cancer database (NCDB). ASCO Annual Meeting, (2005), abstr 3526.

Steele, G. D. Jr., Herndon, J. E., Bleday, R., et al. Sphincter-sparing treatment for distal rectal adenocarcinoma. Ann Surg Oncol, 6 (1996), 433–41.CrossRefGoogle Scholar

Russell, A. H., Harris, J., Rosenberg, P. J., et al. Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long-term results of radiation therapy oncology group protocol 89–02. Int J Radiat Oncol Biol Phys, 46 (2000), 313–22.CrossRefGoogle ScholarPubMed

Kim, C. J., Yeatman, T. J., Coppola, D., et al. Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann Surg, 234 (2001), 352–8, discussion 358–9.CrossRefGoogle ScholarPubMed

Lezoche, E., Guerrieri, M., Paganini, A. M., et al. Long-term results in patients with T2-3 N0 distal rectal cancer undergoing radiotherapy before transanal endoscopic microsurgery. Br J Surg, 92 (2005), 1546–52.CrossRefGoogle ScholarPubMed

Gerard, J. P., Ayzac, L., Coquard, R., et al. Endocavitary irradiation for early rectal carcinomas T1 (T2). A series of 101 patients treated with the Papillon's technique. Int J Radiat Oncol Biol Phys, 34 (1996), 775–83.CrossRefGoogle ScholarPubMed

Lavertu, S., Schild, S. E., Gunderson, L. L., et al. Endocavitary radiation therapy for rectal adenocarcinoma: 10-year results. Am J Clin Oncol, 26 (2003), 508–12.CrossRefGoogle ScholarPubMed

Coatmeur, O., Truc, G., Barillot, I., et al. Treatment of T1-T2 rectal tumors by contact therapy and interstitial brachytherapy. Radiother Oncol, 70 (2004), 177–82.CrossRefGoogle ScholarPubMed

Gerard, J. P., Chapet, O., Ramaioli, A., et al. Long-term control of T2-T3 rectal adenocarcinoma with radiotherapy alone. Int J Radiat Oncol Biol Phys, 54 (2002), 142–9.CrossRefGoogle ScholarPubMed

Willett, C. G., Fung, C. Y., Kaufman, D. S., et al. Postoperative radiation therapy for high-risk colon carcinoma. J Clin Oncol, 11 (1993), 1112–17.CrossRefGoogle ScholarPubMed

Martenson, J. A. Jr., Willett, C. G., Sargent, D. J., et al. Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130. J Clin Oncol, 22 (2004), 3277–83.CrossRefGoogle ScholarPubMed

Adson, M. A. Resection of liver metastases – when is it worthwhile?World J Surg, 11 (1987), 511–20.CrossRefGoogle ScholarPubMed

Borgelt, B. B., Gelber, R., Brady, L. W., et al. The palliation of hepatic metastases: results of the Radiation Therapy Oncology Group pilot study. Int J Radiat Oncol Biol Phys, 7 (1981), 587–91.CrossRefGoogle ScholarPubMed

Phillips, R., Karnofsky, D. A., Hamilton, L. D., et al. Roentgen therapy of hepatic metastases. Am J Roentgenol Radium Ther Nucl Med, 71 (1954), 826–34.Google ScholarPubMed

Prasad, B., Lee, M. S., and Hendrickson, F. R. Irradiation of hepatic metastases. Int J Radiat Oncol Biol Phys, 2 (1977), 129–32.CrossRefGoogle ScholarPubMed

Sherman, D. M., Weichselbaum, R., Order, S. E., et al. Palliation of hepatic metastasis. Cancer, 41 (1978), 2013–17.3.0.CO;2-T>CrossRefGoogle ScholarPubMed

Robertson, J. M., Lawrence, T. S., Walker, S., et al. The treatment of colorectal liver metastases with conformal radiation therapy and regional chemotherapy. Int J Radiat Oncol Biol Phys, 32 (1995), 445–50.CrossRefGoogle ScholarPubMed

Jackson, A., Ten Haken, R. K., Robertson, J. M., et al. Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int J Radiat Oncol Biol Phys, 31 (1995), 883–91.CrossRefGoogle ScholarPubMed

Dawson, L. A., McGinn, C. J., Normolle, D., et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol, 18 (2000), 2210–18.CrossRefGoogle ScholarPubMed

Ben-Josef, E., Normolle, D., Ensminger, W. D., et al. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol, 23 (2005), 8739–47.CrossRefGoogle ScholarPubMed

Vermaas, M., Ferenschild, F. T., Nuyttens, J. J., et al. Preoperative radiotherapy improves outcome in recurrent rectal cancer. Dis Colon Rectum, 48 (2005), 918–28.CrossRefGoogle ScholarPubMed

Mohiuddin, M., Marks, G., and Marks, J.Long-term results of reirradiation for patients with recurrent rectal carcinoma. Cancer, 95 (2002), 1144–50.CrossRefGoogle ScholarPubMed